DEF 14A: Focus Universal Seeks Shareholder Approval for Increased Share Authorization, Board Member Elections, and Auditor Ratification
Definitive Proxy Statement
Focus Universal is asking shareholders to vote on key proposals including electing board members, ratifying the auditor, and increasing the number of authorized shares at the upcoming annual meeting.
Summary
- Focus Universal Inc. is holding its 2024 Annual Meeting of Shareholders on November 29, 2024, at its headquarters in Ontario, California.
- Shareholders will vote on three key proposals: electing five members to the Board of Directors, ratifying the selection of Weinberg & Company, P.A. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2023, and approving an amendment to the Articles of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000.
- The Board of Directors has fixed October 2, 2024, as the record date for determining shareholders entitled to vote at the Annual Meeting.
- As of September 30, 2024, there were approximately 68,667,760 shares of Common Stock issued and outstanding.
- The Board of Directors recommends voting for all director nominees, ratifying the auditor, and approving the increase in authorized shares.
Sentiment
Score: 6
Explanation: The document is a standard proxy statement, presenting routine matters for shareholder vote. While the increase in authorized shares could be seen as a positive for future growth, it also carries the risk of dilution. The sentiment is neutral to slightly positive.
Positives
- The proposed increase in authorized shares provides the company with greater flexibility for future financing and strategic transactions.
- The Board of Directors is composed of a majority of independent directors, ensuring strong corporate governance.
- The company has established Audit, Compensation, and Nominating and Corporate Governance Committees to oversee key areas of corporate governance.
Negatives
- The increase in authorized shares could potentially dilute existing shareholders' ownership if new shares are issued.
- The company has engaged in related party transactions, including loans from the CEO and shareholders, which could raise concerns about conflicts of interest.
- Two of the five board members are not independent.
Risks
- Failure to obtain shareholder approval for the proposed increase in authorized shares could limit the company's ability to raise capital and pursue strategic opportunities.
- Issuance of additional shares could dilute existing shareholders' ownership and voting rights.
- Related party transactions could create potential conflicts of interest and may not be on terms as favorable as those available from unrelated parties.
Future Outlook
The company intends to use the additional authorized shares for future financing, acquisitions, and other general corporate purposes, but has no definitive plans at this time.
Management Comments
- The Board believes that additional authorized shares of Common Stock will enable us to take timely advantage of market conditions and favorable financing and acquisition opportunities that become available to us.
Industry Context
Many companies seek to increase their authorized share capital to provide flexibility for future growth and strategic initiatives. This proposal aligns with common corporate practices.
Comparison to Industry Standards
- The document mentions a survey of shares of Common Stock authorized and shares of Common Stock outstanding at our peer group companies, to strike the appropriate balance so that we do not have what some shareholders might view as an unreasonably high number of authorized shares of Common Stock that are unissued or reserved for issuance.
- However, the document does not list any specific comparable companies, projects, or results.
Related Party Transactions
- Revenue generated from Vitashower Corp., a company owned by the Chief Executive Officer's wife, amounted to $0 and $41,536 for the years ended December 31, 2023 and 2022, respectively.
- Service revenue generated from the installation of home security equipment by AT Tech and AVX for one of the Company's directors amounted to $65,543 and $8,246 for the years ended December 31, 2023 and 2022, respectively.
- On September 7, 2023, the Company entered into a loan agreement with Golden Sunrise Investment LLC in the amount of $1,000,000.
- On April 2, 2024, the Company entered into a two-year loan agreement with the Company's CEO Desheng Wang for the amount of $300,000.
Stakeholder Impact
- Approval of the increase in authorized shares could impact shareholders through potential dilution.
- The election of directors will determine the leadership and strategic direction of the company, impacting all stakeholders.
- The ratification of the auditor ensures the integrity of the company's financial reporting, benefiting shareholders and creditors.
Next Steps
- Shareholders will vote on the proposals at the Annual Meeting on November 29, 2024.
- The Board will determine whether to file the Certificate of Amendment with the Secretary of State of the State of Nevada if shareholders approve the proposal.
Key Dates
| Date | Description |
|---|---|
| December 29, 2014 | Dr. Desheng Wang appointed as Chief Executive Officer, Secretary, and director of the Company |
| October 21, 2015 | Dr. Edward Lee appointed President and director of the Company |
| June 8, 2018 | Michael Pope and Carine Clark appointed as independent directors of the Company |
| December 17, 2018 | The Company adopted the 2018 Stock Option Plan |
| November 15, 2019 | Dr. Lee resigned as President and was appointed as Chairman of the Board |
| November 3, 2021 | Employment agreement date for Irving Kau for the provision of services as VP of Finance |
| November 10, 2021 | Irving Kau served as Focus Universals Vice President of Finance and Head of Investor Relations |
| August 10, 2022 | Sean Warren was appointed as an independent director of the Company |
| November 18, 2022 | Irving Kau was appointed as Chief Financial Officer of the Company |
| September 7, 2023 | The Company entered into a loan agreement with Golden Sunrise Investment LLC in the amount of $1,000,000 |
| January 5, 2024 | Weinberg & Company, P.A. was appointed to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2023 |
| January 16, 2024 | The Company filed a Current Report on Form 8-K with the SEC announcing the change in auditors |
| March 5, 2024 | The Company entered into an addendum to the loan agreement with Golden Sunrise Investment LLC, a related party obtaining an additional secured loan amount of $300,000 |
| April 2, 2024 | The Company entered into a two-year loan agreement with the Companys CEO Desheng Wang for the amount of $300,000 |
| July 3, 2024 | The principal and interest were paid off on the loan with Golden Sunrise Investment LLC |
| July 9, 2024 | The principal and interest were paid off on the loan with the Companys CEO Desheng Wang |
| September 18, 2024 | Due to the purchase of PIPE shares, Dr. Wang has 22,729,550 shares and Dr. Lee has 12,022,500 shares |
| September 27, 2024 | The Board determined by written consent to approve the Certificate of Amendment, subject to shareholder approval and the Boards discretion to effect the Certificate of Amendment, to authorize an additional 75 million shares of Common Stock |
| October 1, 2024 | Date of the Proxy Statement |
| October 2, 2024 | Record Date for determining shareholders entitled to notice of and to vote at the Annual Meeting |
| November 29, 2024 | Date of the 2024 Annual Meeting of Shareholders |
| December 31, 2024 | Deadline for shareholders to submit proposals for the 2025 Annual Meeting of Shareholders |
| April 1, 2026 | Due date of the principal and interest amount for the loan agreement with the Companys CEO Desheng Wang |
Keywords
Annual Meeting, Proxy Statement, Shareholders, Board of Directors, Authorized Shares, Common Stock, Weinberg & Company, Auditor Ratification, Director Election, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.